Diabetes in COVID-19: Prevalence, pathophysiology, prognosis and practical considerations

Background and aims High prevalence of diabetes makes it an important comorbidity in patients with COVID-19. We sought to review and analyze the data regarding the association between diabetes and COVID-19, pathophysiology of the disease in diabetes and management of patients with diabetes who develop COVID-19 infection. Methods PubMed database and Google Scholar were searched using the key terms ‘COVID-19’, ‘SARS-CoV-2’, ‘diabetes’, ‘antidiabetic therapy’ up to April 2, 2020. Full texts of the retrieved articles were accessed. Results There is evidence of increased incidence and severity of COVID-19 in patients with diabetes. COVID-19 could have effect on the pathophysiology of diabetes. Blood glucose control is important not only for patients who are infected with COVID-19, but also for those without the disease. Innovations like telemedicine are useful to treat patients with diabetes in today’s times.

• Publication year

  2020

• Venue

  Diabetes & metabolic syndrome

• Publication date

  2020-04-09

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.dsx.2020.04.004PMID 32298981PMCID 7195120
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Clinical Characteristics of Coronavirus Disease 2019 in China

  2020cited by this paper
• Polymorphisms in dipeptidyl peptidase 4 reduce host cell entry of Middle East respiratory syndrome coronavirus

  2020cited by this paper
• [Asymptomatic infection of COVID-19 and its challenge to epidemic prevention and control].

  2020cited by this paper
• Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study

  2020cited by this paper
• Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China.

  2020cited by this paper
• Clinical characteristics of novel coronavirus cases in tertiary hospitals in Hubei Province

  2020cited by this paper
• [The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China].

  2020cited by this paper
• Clinical characteristics of 140 patients infected with SARS‐CoV‐2 in Wuhan, China

  2020cited by this paper
• Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention.

  2020cited by this paper
• Clinical Characteristics of Coronavirus Disease 2019 in China

  2020cited by this paper
• Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study

  2020cited by this paper
• [Clinical characteristics and outcomes of 112 cardiovascular disease patients infected by 2019-nCoV].

  2020cited by this paper
• Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study

  2020cited by this paper
• Comorbidities and multi-organ injuries in the treatment of COVID-19

  2020cited by this paper
• Virtually Perfect? Telemedicine for Covid-19.

  2020cited by this paper
• Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China

  2020cited by this paper
• Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?

  2020cited by this paper
• Clinical considerations for patients with diabetes in times of COVID-19 epidemic

  2020cited by this paper
• Emerging COVID-19 coronavirus: glycan shield and structure prediction of spike glycoprotein and its interaction with human CD26

  2020influential reference
• The novel coronavirus 2019 (2019-nCoV) uses the SARS-coronavirus receptor ACE2 and the cellular protease TMPRSS2 for entry into target cells

  2020cited by this paper
• Neutrophil-to-Lymphocyte Ratio Predicts Severe Illness Patients with 2019 Novel Coronavirus in the Early Stage

  2020cited by this paper
• Hiding in Plain Sight: an Approach to Treating Patients with Severe COVID-19 Infection

  2020influential reference
• Case-Fatality Rate and Characteristics of Patients Dying in Relation to COVID-19 in Italy.

  2020cited by this paper
• All Feet On Deck-The Role of Podiatry During the COVID-19 Pandemic: Preventing hospitalizations in an overburdened healthcare system, reducing amputation and death in people with diabetes.

  2020cited by this paper
• Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study

  2020cited by this paper
• Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19)

  2020cited by this paper
• COVID-19 and diabetes: Can DPP4 inhibition play a role?

  2020cited by this paper
• Renin–Angiotensin–Aldosterone System Inhibitors in Patients with Covid-19

  2020cited by this paper
• Covid-19 in Critically Ill Patients in the Seattle Region — Case Series

  2020cited by this paper
• Covid‐19 and diabetes mellitus: unveiling the interaction of two pandemics

  2020cited by this paper
• Preliminary Estimates of the Prevalence of Selected Underlying Health Conditions Among Patients with Coronavirus Disease 2019 — United States, February 12–March 28, 2020

  2020cited by this paper
• Comorbidities in COVID-19: Outcomes in hypertensive cohort and controversies with renin angiotensin system blockers

  2020cited by this paper
• Exploring diseases/traits and blood proteins causally related to expression of ACE2, the putative receptor of 2019-nCov: A Mendelian Randomization analysis

  2020cited by this paper
• Effects of hypertension, diabetes and coronary heart disease on COVID-19 diseases severity: a systematic review and meta-analysis

  2020cited by this paper
• Hypertension and Diabetes Delay the Viral Clearance in COVID-19 Patients

  2020cited by this paper
• Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis

  2020cited by this paper
• Joint HFSA/ACC/AHA Statement Addresses Concerns Re: Using RAAS Antagonists in COVID-19

  2020cited by this paper
• Neutrophil-to-lymphocyte ratio predicts critical illness patients with 2019 coronavirus disease in the early stage

  2020cited by this paper
• Exploring Diseases/Traits and Blood Proteins Causally Related to Expression of ACE2, the Putative Receptor of SARS-CoV-2: A Mendelian Randomization Analysis Highlights Tentative Relevance of Diabetes-Related Traits

  2020cited by this paper
• Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

  2020cited by this paper
• Prevalence of comorbidities in the novel Wuhan coronavirus (COVID-19) infection: a systematic review and meta-analysis

  2020cited by this paper
• Impacts of metformin on tuberculosis incidence and clinical outcomes in patients with diabetes: a systematic review and meta-analysis

  2019cited by this paper
• Metformin use mitigates the adverse prognostic effect of diabetes mellitus in chronic obstructive pulmonary disease

  2019cited by this paper
• Intravenous Insulin Infusion Protocol Compared With Subcutaneous Insulin for the Management of Hyperglycemia in Critically Ill Adults

  2019cited by this paper
• Reduced mortality from lower respiratory tract disease in adult diabetic patients treated with metformin

  2019cited by this paper
• Comorbid diabetes results in immune dysregulation and enhanced disease severity following MERS-CoV infection.

  2019influential reference
• Dipeptidyl peptidase-4 inhibitors can inhibit angiotensin converting enzyme.

  2019cited by this paper
• Metformin Mediates Protection against Legionella Pneumonia through Activation of AMPK and Mitochondrial Reactive Oxygen Species

  2018cited by this paper
• Comparison of Glycemic Control between Continuous Regular Insulin Infusion and Single-dose Subcutaneous Insulin Glargine Injection in Medical Critically Ill Patients

  2018cited by this paper
• Impact of angiotensin-converting enzyme inhibitors and statins on viral pneumonia

  2018cited by this paper
• Comparison of subcutaneous insulin aspart and intravenous regular insulin for the treatment of mild and moderate diabetic ketoacidosis in pediatric patients

  2018cited by this paper
• Plasma levels of the proprotein convertase furin and incidence of diabetes and mortality

  2018cited by this paper
• The Use of Statins and Risk of Community-Acquired Pneumonia

  2017cited by this paper
• Preadmission Use of Calcium Channel Blockers and Outcomes After Hospitalization With Pneumonia: A Retrospective Propensity-Matched Cohort Study

  2017cited by this paper
• Use of oral antidiabetic agents and risk of community‐acquired pneumonia: a nested case–control study

  2017cited by this paper
• The vasoprotective axes of the renin‐angiotensin system: Physiological relevance and therapeutic implications in cardiovascular, hypertensive and kidney diseases

  2017cited by this paper
• Characterization of ACE and ACE2 Expression within Different Organs of the NOD Mouse

  2017cited by this paper
• Continuous Glucose Monitor Interference With Commonly Prescribed Medications: A Pilot Study

  2017cited by this paper
• Prevalence of Diabetes in the 2009 Influenza A (H1N1) and the Middle East Respiratory Syndrome Coronavirus: A Systematic Review and Meta-Analysis

  2016cited by this paper
• Risk Factors for Primary Middle East Respiratory Syndrome Coronavirus Illness in Humans, Saudi Arabia, 2014

  2016cited by this paper
• Prevalence of comorbidities in the Middle East respiratory syndrome coronavirus (MERS-CoV): a systematic review and meta-analysis

  2016cited by this paper
• Activation of the GLP-1 Receptor by Liraglutide Increases ACE2 Expression, Reversing Right Ventricle Hypertrophy, and Improving the Production of SP-A and SP-B in the Lungs of Type 1 Diabetes Rats.

  2015cited by this paper
• Statins May Decrease the Fatality Rate of Middle East Respiratory Syndrome Infection

  2015cited by this paper
• Pioglitazone Upregulates Angiotensin Converting Enzyme 2 Expression in Insulin-Sensitive Tissues in Rats with High-Fat Diet-Induced Nonalcoholic Steatohepatitis

  2014cited by this paper
• Continuous glucose monitoring in the surgical intensive care unit: Concordance with capillary glucose

  2014cited by this paper
• Substance P Increases Sympathetic Activity During Combined Angiotensin-Converting Enzyme and Dipeptidyl Peptidase-4 Inhibition

  2014cited by this paper
• Angiotensin-converting enzyme 2 (ACE2) mediates influenza H7N9 virus-induced acute lung injury

  2014cited by this paper
• Middle East Respiratory Syndrome Coronavirus: A Case-Control Study of Hospitalized Patients

  2014cited by this paper
• Role of the Spike Glycoprotein of Human Middle East Respiratory Syndrome Coronavirus (MERS-CoV) in Virus Entry and Syncytia Formation

  2013influential reference
• The Spike Protein of the Emerging Betacoronavirus EMC Uses a Novel Coronavirus Receptor for Entry, Can Be Activated by TMPRSS2, and Is Targeted by Neutralizing Antibodies

  2013influential reference
• Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC

  2013cited by this paper
• Feasibility of fully automated closed-loop glucose control using continuous subcutaneous glucose measurements in critical illness: a randomized controlled trial

  2013cited by this paper
• Diabetes and the Severity of Pandemic Influenza A (H1N1) Infection

  2010cited by this paper
• Interactive Hemodynamic Effects of Dipeptidyl Peptidase-IV Inhibition and Angiotensin-Converting Enzyme Inhibition in Humans

  2010cited by this paper
• Binding of SARS coronavirus to its receptor damages islets and causes acute diabetes

  2009cited by this paper
• Dipeptidyl Peptidase-IV Inhibitor Use Associated With Increased Risk of ACE Inhibitor-Associated Angioedema

  2009cited by this paper
• EFFECTS OF DIPEPTIDYL PEPTIDASE IV INHIBITION ON ARTERIAL BLOOD PRESSURE

  2008cited by this paper
• Plasma glucose levels and diabetes are independent predictors for mortality and morbidity in patients with SARS

  2006cited by this paper
• Current Perspectives on the Use of Continuous Subcutaneous Insulin Infusion in the Acute Care Setting and Overview of Therapy

  2004cited by this paper
• Bacterial pneumonia: comparison between diabetics and non-diabetics

  2001cited by this paper
• Dipeptidyl-peptidase IV (CD26)--role in the inactivation of regulatory peptides.

  1999cited by this paper
• THE WORLD HEALTH ORGANIZATION

  1954cited by this paper

• Association between nursing workload and staff size with the occurrence of adverse events and deaths of patients with COVID‐19: A retrospective cohort study

  2025cites this paper
• The prevalence of symptomatic COVID-19 infection among pregnant women and its relationship with pregnancy outcomes: a retrospective review of the medical records in North East Iran

  2025cites this paper
• Nurse-led social media-based education in diabetic patients: Effects on COVID-19 fear and self-care – A 6-month follow-up trial

  2025cites this paper
• Relationship between periodontitis, type 2 diabetes mellitus and COVID-19 disease: a narrative review

  2025cites this paper
• The Effect of Diabetes Mellitus and Glycemic Parameters on the Prognosis of COVID‐19 Disease

  2025cites this paper
• Intersecting pathways of pandemic emergence, tobacco control and noncommunicable diseases: a contemporary synthesis of global health determinants and policy implications

  2025cites this paper
• A Review of Efficacy and Potential Mechanism of Metformin in the Treatment of Coronavirus Disease 2019 in Diabetes Patient

  2025cites this paper
• SGLT2 Inhibitors in COVID-19: Umbrella Review, Meta-Analysis, and Bayesian Sensitivity Assessment

  2025cites this paper
• Prevalent clinical symptoms, comorbidities, and treatment outcomes among COVID-19 patients in Abuja, Nigeria

  2025cites this paper
• Diabetes Mellitus and Multidrug-Resistant Gram-Negative Bacterial Infections in Critically Ill COVID-19 Patients: A Retrospective Observational Study

  2025cites this paper
• Immune dysregulation in type 2 diabetes mellitus: Implications for tuberculosis, COVID-19, and HIV/AIDS

  2025cites this paper
• Knowledge, Attitude and Perceptions of Diabetic Patients Towards Covid-19 Infection in Two Healthcare Facilities in Lagos State, Southwest Nigeria.

  2025cites this paper
• Clinical characteristics and outcomes in patients with diabetes mellitus affected by COVID-19: a retrospective cross-sectional study from a tertiary care center in Pakistan

  2025cites this paper
• Case Report: Diagnosis, treatment and follow-up of venous thrombosis in adolescent diabetic patients with SARS-CoV-2

  2025cites this paper
• Perbedaan Parameter Hematologi Neutrophil to Lymphocyte Ratio (NLR) Antara Pasien Diabetes Melitus dan Tanpa Diabetes Melitus berdasarkn Derajat Keparahan Sakit Covid-19

  2025cites this paper
• The Intersection of SARS-CoV-2 and Diabetes

  2025influential citation
• Association of ARDS Severity with Non-Invasive Ventilation Duration in COVID-19 Patients

  2025cites this paper
• A review of the world’s response to COVID-19 and the potential of medicinal plants for future pandemics

  2025cites this paper
• Current Landscape of the Interrelationship Between Periodontitis, Type 2 Diabetes Mellitus, and COVID-19

  2025cites this paper
• The Association Between Race and Risk of COVID-19 Hospitalization: Examining the Contribution of Social Determinants of Health.

  2025cites this paper
• Self-Reported Post-COVID Symptoms at 18 Months After Infection Among Adults in Southern Brazil: A Cross-Sectional Study

  2025cites this paper
• A community-based health assessment among residents of affordable housing in San Francisco’s Hunters Point

  2025cites this paper
• Age-Adjusted in-Hospital Mortality in Patients with COVID-19 Infection: Impact of the Presence of Multiple Comorbidities

  2024cites this paper
• Association among diabetes, cardiovascular disease and mortality in patients hospitalised for COVID-19: an analysis of the American Heart Association COVID-19 CVD Registry

  2024cites this paper
• Evaluation of Inflammatory Markers in Patients with COVID-19 Combined with Type 2 Diabetes Mellitus

  2024cites this paper
• Cardioprotective effects of vaccination in hospitalized patients with COVID-19

  2024cites this paper
• EpiGePT: a pretrained transformer-based language model for context-specific human epigenomics

  2024cites this paper
• Glycemic Management and Lipid Profile in Individuals with Type 2 Diabetes During The COVID-19 Pandemic: An Analytical Cross-Sectional Study

  2024cites this paper
• Incidence and severity of COVID-19 among HIV positive patients with existing co-morbidities

  2024cites this paper
• Evaluating the protective effectiveness and risk factors of ursodeoxycholic acid on COVID-19 among outpatients

  2024cites this paper
• COMPONENTS OF METABOLIC SYNDROME AS A RISK FACTOR FOR COVID-19 IN INDIA

  2024cites this paper
• COVID-19 and Diabetes: Risks, outcomes, and management strategies for vulnerable populations

  2024cites this paper
• Efficient clinical decision-making process via AI-based multimodal data fusion: A COVID-19 case study

  2024cites this paper
• Role of the receptor for advanced glycation end products in the severity of SARS-CoV-2 infection in diabetic patients

  2024cites this paper
• New Onset Diabetes After COVID 19 (NODAC) is predominantly due to exacerbated Insulin Resistance (IR) rather than beta cell dysfunction: Lessons from tertiary care hospital data during confluence of two epidemics

  2024cites this paper
• Vitamin D: A key player in COVID-19 immunity and lessons from the pandemic to combat immune-evasive variants

  2024cites this paper
• A reduced proteomic signature in critically ill Covid-19 patients determined with plasma antibody micro-array and machine learning

  2024cites this paper
• PRESCRIPTION AUDIT AND EFFECTS OF COMORBIDITIES ON INDOOR COVID-19 PATIENTS OF A TERTIARY CARE TEACHING HOSPITAL

  2024cites this paper
• COVID-19 and Type 1 Diabetes.

  2024cites this paper
• Severe COVID-19 infection: An institutional review and literature overview

  2024cites this paper
• Demographics, Clinical Characteristics and In-Hospital Outcome of Coronavirus Disease 2019 (COVID-19) Patients With or Without Diabetes Mellitus

  2024cites this paper
• Zinc pathogenic importance in correcting immunity and restoring public health in the post-COVID period: An overview.

  2024cites this paper
• Assessment of COVID-19 patients’ outcome based on clinical profile, laboratory parameters, and clinical management: A retrospective observational study

  2024cites this paper
• Age-dependent effects of lockdown and post-lockdown periods on HbA1c during the COVID-19 pandemic: A 3-year longitudinal cohort study

  2024influential citation
• Impact of COVID-19 and recovery of routine diabetic retinopathy digital screening across different regions in England: an analysis of publicly available data

  2024cites this paper
• Diabetes and Infectious Diseases with a Focus on Melioidosis

  2024cites this paper
• FURIN, IFNL4, and TLR2 gene polymorphisms in relation to COVID-19 severity: a case–control study in Egyptian patients

  2024cites this paper
• Comorbidities affecting re-admission and survival in COVID-19: Application of joint frailty model

  2024cites this paper
• Ischemic stroke and COVID-19 infection — a review of clinical case reports

  2024cites this paper
• Mortality and COVID Infection: Predictors of Mortality 10 Months after Discharge

  2024cites this paper
• Insulin Adjustments for Hospitalized COVID-19 Patients on a Fixed Dexamethasone Protocol

  2024cites this paper
• A Critical Review on the Long-term COVID-19 Impacts on Patients with Diabetes.

  2024cites this paper
• Is Metformin Use Associated with a More Favorable COVID-19 Course in People with Diabetes?

  2024cites this paper
• Diabetes and COVID-19 Outcomes: An Analysis of Freeman Health System Patients

  2024cites this paper
• Impact of digital services on healthcare and social welfare: An umbrella review.

  2024cites this paper
• D-dimer level and inflammatory markers in COVID-19 patients with and without diabetes mellitus - A comparative study during the first wave of the pandemic

  2024cites this paper
• Obesity as a Risk Factor for Complications and Mortality in Individuals with SARS-CoV-2: A Systematic Review

  2024cites this paper
• SARS-CoV2 Viral Ct Values Correlation with Some Patients’ Factors and Disease Outcome

  2024cites this paper
• Prevalence and short-term clinical impacts of new-onset diabetes mellitus among patients with COVID-19 in jazan region, Saudi Arabia

  2024influential citation
• Elevated risk of pre-diabetes and diabetes in people with past history of COVID-19 in northeastern Nigeria

  2024cites this paper
• Correlation of NLR and D-dimer Levels with Clinical Severity of COVID-19 and Determination of Cut-off Values at a Hospital in Cirebon

  2024influential citation
• Potential use of plant-based therapeutics for the management of SARS-COV2 infection in Diabetes mellitus- A review

  2024cites this paper
• International Difference of Tobacco Related COVID-19 Severity

  2024cites this paper
• Iranian patients with diabetes and COVID-19-associated mucormycosis: Characteristics, manifestations, and mortality risk factors

  2024cites this paper
• Type 2 Diabetes Status, Diabetes Complication Severity Index Scores, and Their Relationship With COVID-19 Severity: A Retrospective Cohort Study of Hospitalized Patients in a Southwest Virginia Health System

  2024cites this paper
• Can euglycemic Diabetic Ketoacidosis Caused by SGLT2 Inhibitors be avoided in Covid-19 and other acute Infections?

  2024cites this paper
• Risk of COVID-19 among patients with respiratory illnesses and comorbidities at Eastern Province of Sri Lanka: A retrospective study

  2024cites this paper
• Overview and Outcomes of Patients Hospitalised with COVID-19 Pneumonia in Rīga East University Hospital

  2024cites this paper
• Liver injury in COVID-19: an insight into pathobiology and roles of risk factors

  2024cites this paper
• Research Progress on the Weak Immune Response to the COVID-19 Vaccine in Patients with Type 2 Diabetes

  2024cites this paper
• Prevalence of Diabetes, Ketosis, and Ketoacidosis and Their Correlation With Mortality in Critical COVID-19 Patients: A Single-Center Retrospective Study

  2024cites this paper
• Effects of Anthocyanins on Components of Metabolic Syndrome—A Review

  2024cites this paper
• COVID-19 with high-sensitivity CRP associated with worse dynamic clinical parameters and outcomes

  2024cites this paper
• Study of fungal rhinosinusitis among Covid patients at a tertiary care hospital

  2024cites this paper
• COVID-19 patient profiles over four waves in Barcelona metropolitan area: A clustering approach

  2024cites this paper
• Factors Associated with Length of Hospitalization in Patients with Diabetes and Mild COVID-19: Experiences from a Tertiary University Center in Serbia

  2024cites this paper
• T‐cell immunity against Severe Acute Respiratory Syndrome Coronavirus 2 proteins in patients with type 1 diabetes

  2024cites this paper
• Explainable learning to analyze the outcome of COVID-19 patients using clinical data

  2023cites this paper
• Effect of the SARS COV-2 virus on diabetes symptoms, diagnostics, and treatment

  2023cites this paper
• Patients with COVID-19 Pneumonia Admitted to an Intensive Care Unit (ICU) at a Community Hospital in Flint, Michigan, in Early 2020: Characteristics and Mortality

  2023cites this paper
• Profile of diabetes mellitus therapy in COVID-19 patients with diabetes mellitus in Kogabwilhan II Emergency Hospital Surabaya

  2023cites this paper
• Reproduction number projection for the COVID-19 pandemic

  2023cites this paper
• The Effect of a Patient Activation Tailored Intervention on Type 2 Diabetes Self-Management and Clinical Outcomes: A Study from Saudi Arabian Primary Care Settings

  2023cites this paper
• Hubungan riwayat kontrol gula darah dengan luaran penanganan ICU pada pasien Covid-19 beriwayat Diabetes Melitus di RSUD Ciawi Bogor

  2023cites this paper
• Diabetes mellitus and COVID-19: living with double risk

  2023cites this paper
• - VACCINATION STATUS AND THE SEVERITY OF COVID-19 PATIENTS

  2023cites this paper
• Type 2 diabetes mellitus in combination with COVID-19: clinical and metabolic characteristics of patients and prediction of mortality risk

  2023cites this paper
• Novel Substituted Azoloazines with Anticoagulant Activity

  2023cites this paper
• Factores de riesgo asociados a mortalidad en pacientes con síndrome de insuficiencia respiratoria aguda severo por COVID-19 en la Unidad de Terapia Intensiva

  2023cites this paper
• Insulin Requirements During Severe COVID-19 Were Relatively Low in Japanese Patients With Type 2 Diabetes: Two Case Reports

  2023cites this paper
• Lower odds of COVID-19-related mortality in hospitalised patients with type II diabetes mellitus: A single-centre study

  2023cites this paper
• Pulmonary complications of COVID-19 in patients with diabetes

  2023cites this paper
• Angiotensin-converting enzyme 2: virus accomplice or host defender?

  2023cites this paper
• Tuberculosis and COVID-19 in the elderly: factors driving a higher burden of disease

  2023cites this paper
• Antidiabetic drug profile of COVID-19 patients with comorbid diabetes mellitus

  2023cites this paper
• Evaluation Cholesterol and Triglycerides Levels for Type One Diabetes Patients

  2023cites this paper
• Risk of severe infection in patients with non‐alcoholic fatty liver disease: Implication on clinical management

  2023cites this paper
• Developing a COVID-19 Mortality Prediction (CoMPred) Indicator for ICU Diabetic Patients Treated with Tocilizumab in Saudi Arabia: A Proof-of-Concept Study

  2023cites this paper
• Diagnosis of latent autoimmune diabetes after SARS–Cov2 vaccination in adult patients previously diagnosed with type 2 diabetes mellitus

  2023cites this paper
• In silico Study to Optimize the Dosage of Oleuropein with Metformin in Diabetes Management

  2023cites this paper